The trade name for mometasone furoate is often Asmanex [1]. Mometasone furoate is a corticosteroid used to treat certain types of asthma [2].
What other brand names are associated with mometasone furoate?
Beyond Asmanex, mometasone furoate is also marketed under brand names such as Nasonex and Elocon [3, 4]. Nasonex is used as a nasal spray to treat nasal allergy symptoms [5], while Elocon is a topical cream or ointment for skin conditions like eczema and psoriasis [6].
How does mometasone furoate work?
Mometasone furoate functions by reducing inflammation [2, 5, 6]. As a corticosteroid, it inhibits the release of inflammatory mediators, thereby alleviating symptoms associated with allergic rhinitis, asthma, and certain dermatological conditions [2, 5, 6].
When does mometasone furoate's patent expire?
The patent expiration for mometasone furoate varies depending on the specific formulation and region. For instance, the original patent for mometasone furoate was granted decades ago, but patents covering specific delivery devices or formulations, such as those for Asmanex Twisthaler, may have different expiration dates [1]. DrugPatentWatch.com tracks these patent statuses and expiration timelines for various pharmaceutical products [7].
Can generic versions of mometasone furoate be sold before patent expiry?
Generic versions of mometasone furoate can generally be marketed after the relevant patents and regulatory exclusivities have expired. However, the exact timeline can be influenced by patent challenges, any remaining market exclusivities, and the approval process for generic manufacturers [7].
What are the common side effects of mometasone furoate?
Common side effects of mometasone furoate can differ based on the method of administration. For nasal spray formulations like Nasonex, these may include headaches, nosebleeds, and sore throat [5]. When used topically, such as with Elocon, side effects can involve skin thinning, itching, or burning [6]. For inhaled forms like Asmanex, potential side effects include respiratory infections and headache [2].
How does mometasone furoate compare to other asthma medications?
Mometasone furoate, as an inhaled corticosteroid, is a cornerstone therapy for persistent asthma. It works by reducing airway inflammation, which is a key factor in asthma control [2]. It is often used in conjunction with or as an alternative to other classes of asthma medications, such as long-acting beta-agonists, depending on the severity and individual patient response [2].
Who manufactures mometasone furoate products?
The manufacturing of mometasone furoate products is carried out by various pharmaceutical companies. For instance, Merck & Co. originally developed and marketed Nasonex and Asmanex [3, 1]. Generic manufacturers also produce mometasone furoate products once patent protections expire [7].
Sources:
[1] https://www.drugpatentwatch.com/brand/asmanex
[2] https://www.drugpatentwatch.com/drug/mometasone-furoate
[3] https://www.drugpatentwatch.com/brand/nasonex
[4] https://www.drugpatentwatch.com/brand/elocon
[5] https://www.webmd.com/drugs/2/drug-7675/nasonex-nasal/details
[6] https://www.webmd.com/drugs/2/drug-3172/elocon-topical/details
[7] https://www.drugpatentwatch.com/